Legend Biotech Corporation

05/18/2022 | Press release | Distributed by Public on 05/18/2022 06:37

Legend Biotech to Highlight Continued Progress in the Treatment of Multiple Myeloma with Updated Data from BCMA CAR-T Studies at 2022 ASCO and EHA